The first-in-man randomized trial of a beta3 adrenoceptor agonist in chronic heart failure: the BEAT-HF trial-Reference-Cited by-同舟云学术

The first-in-man randomized trial of a beta3 adrenoceptor agonist in chronic heart failure: the BEAT-HF trial

Published:2016-12-18 Issue:4 Volume:19 Page:566-575
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Bundgaard Henning¹,Axelsson Anna¹,Hartvig Thomsen Jakob¹,Sørgaard Mathias¹,Kofoed Klaus F.¹²,Hasselbalch Rasmus³,Fry Natasha A.S.⁴,Valeur Nana⁵,Boesgaard Søren¹,Gustafsson Finn¹,Køber Lars¹,Iversen Kasper³,Rasmussen Helge H.⁶

Affiliation:

1. Department of Cardiology, The Heart Centre, Rigshospitalet; University of Copenhagen; Copenhagen Denmark

2. Department of Radiology, Rigshospitalet; University of Copenhagen; Copenhagen Denmark

3. Department of Cardiology, Herlev Hospital; University of Copenhagen; Copenhagen Denmark

4. University of Sydney; Sydney Australia

5. Department of Cardiology, Bispebjerg Hospital; University of Copenhagen; Copenhagen Denmark

6. Department of Cardiology; Royal North Shore Hospital and University of Sydney; Sydney Australia

Funder

Heart Centre Research Foundation

Rigshospitalet

A.P. Møller and Chastine Mc-Kinney Møller Foundation

Novo Nordic Foundation

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology;Tarone;Eur J Heart Fail,2014

2. Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium;Moniotte;Circulation,2001

3. Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor;Liggett;Proc Natl Acad Sci USA,1993

4. beta3-adrenoceptors in the cardiovascular system: putative roles in human pathologies;Rozec;Pharmacol Ther,2006

5. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle;Gauthier;J Clin Invest,1998

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiological and metabolic functions of the β3-adrenergic receptor and an approach to therapeutic achievements;Journal of Physiology and Biochemistry;2024-08-15

2. Protective Effects of Beta-3 Adrenoceptor Agonism on Mucosal Integrity in Hyperoxia-Induced Ileal Alterations;Antioxidants;2024-07-18

3. Research progress on the protective effect of hormones and hormone drugs in myocardial ischemia-reperfusion injury;Biomedicine & Pharmacotherapy;2024-07

4. ENDOGENOUS β3-ADRENERGIC RECEPTOR ACTIVATION ALLEVIATES SEPSIS-INDUCED CARDIOMYOCYTE APOPTOSIS VIA PI3K/AKT SIGNALING PATHWAY;Shock;2024-03-25

5. First-in-man trial of β3-adrenoceptor agonist treatment in chronic heart failure – impact on diastolic function.;Journal of Cardiovascular Pharmacology;2024-03-05